分子モデリングの世界市場：洞察、競合情勢、市場予測：2030年

世界の分子モデリングの市場規模は、2024年～2030年の予測期間中に14.73％のCAGRで拡大すると予測されています。分子モデリング市場は、がん、心血管疾患、肺疾患、腎臓疾患などの慢性疾患の有病率の上昇により成長が促進されています。新薬発見のための企業間の共同研究や合併の増加も、分子モデリング市場の成長要因の一つです。分子モデリングに関する技術の進歩が進み、医薬品やその他の薬剤の安全性や購入しやすさを向上させることに注目が集まっていることも、予測期間（2024年～2030年）における分子モデリング市場の収益の成長につながると期待されます。

分子モデリング市場の注目すべき促進要因には、慢性疾患の蔓延の増加、業界間の提携や合併の増加、新規薬剤治療薬の発見のための研究開発活動の増加などがあります。

がんは、現在に至るまで永久的な治療法がない致死的な疾患であるため、乳がん、肺がん、子宮頸がん、口腔がんなど、さまざまながん種の有病率の上昇は、がん治療に有効な新薬候補の発見に役立つ分子モデリング市場の成長にとって重要な要因であることが判明しています。世界保健機関（WHO）が2022年に発表したデータによると、2020年には世界で乳がん226万例、肺がん221万例、結腸・直腸がん193万例、前立腺がん141万例、胃がん109万例が報告されます。

当レポートでは、世界の分子モデリング市場について調査し、市場の概要とともに、タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 分子モデリング市場レポートのイントロダクション

第2章 分子モデリング市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 分子モデリング市場の主な要因分析

• 分子モデリング市場の促進要因
• 分子モデリング市場の抑制要因と課題
• 分子モデリング市場の機会

第5章 分子モデリング市場におけるポーターのファイブフォース分析

第6章 分子モデリング市場に対するCOVID-19の影響分析

第7章 分子モデリング市場の概要

• タイプ別
• 用途別
• エンドユーザー別
• 地域別

第8章 分子モデリング市場の世界企業シェア分析-主要3～5社

第9章 分子モデリング市場の企業と製品プロファイル

• Cresset
• Schrodinger, Inc.
• Optibrium, Ltd.
• BioSolveIT GmbH
• Simulations Plus
• Chemical Computing Group ULC
• Certara
• Cadence Molecular Sciences
• Wavefunction, Inc.
• Physiomics Plc
• Genedata AG
• Rosa & Co. LLC.
• Acellera
• Dassault Systemes
• FQS POLAND SP. Z O.O
• Molsoft LLC
• GTB Pharmaceutical
• Intel Corporation
• Nanome Inc
• Agile Molecule

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1 Competitive Analysis
• Table 2 COVID-19 Impact Analysis on Molecular Modeling Market
• Table 3 Molecular Modeling Market in Global (2021-2030)
• Table 4 Molecular Modeling Market in Global by Product Type (2021-2030)
• Table 5 Molecular Modeling Market in Global by Application (2021-2030)
• Table 6 Molecular Modeling Market in Global by End-users (2021-2030)
• Table 7 Molecular Modeling Market in Global by Geography (2021-2030)
• Table 8 Molecular Modeling Market in North America (2021-2030)
• Table 9 Molecular Modeling Market in North America by Country (2021-2030)
• Table 10 Molecular Modeling Market in the US (2021-2030)
• Table 11 Molecular Modeling Market in Canada (2021-2030)
• Table 12 Molecular Modeling Market in Mexico (2021-2030)
• Table 13 Molecular Modeling Market in Europe (2021-2030)
• Table 14 Molecular Modeling Market in Europe by Country (2021-2030)
• Table 15 Molecular Modeling Market in France (2021-2030)
• Table 16 Molecular Modeling Market in Germany (2021-2030)
• Table 17 Molecular Modeling Market in the United Kingdom (2021-2030)
• Table 18 Molecular Modeling Market in Italy (2021-2030)
• Table 19 Molecular Modeling Market in Spain (2021-2030)
• Table 20 Molecular Modeling Market in Rest of Europe (2021-2030)
• Table 21 Molecular Modeling Market in APAC (2021-2030)
• Table 22 Molecular Modeling Market in APAC by Country (2021-2030)
• Table 23 Molecular Modeling Market in China (2021-2030)
• Table 24 Molecular Modeling Market in Japan (2021-2030)
• Table 25 Molecular Modeling Market in India (2021-2030)
• Table 26 Molecular Modeling Market in Australia (2021-2030)
• Table 27 Molecular Modeling Market in South Korea (2021-2030)
• Table 28 Molecular Modeling Market in Rest of APAC (2021-2030)
• Table 29 Molecular Modeling Market in Rest of World (2021-2030)
• Table 30 Molecular Modeling Market in RoW by Region (2021-2030)
• Table 31 Molecular Modeling Market in Middle East (2021-2030)
• Table 32 Molecular Modeling Market in Africa (2021-2030)
• Table 33 Molecular Modeling Market in South America (2021-2030)

List of Figures

• Figure 1 Competitive Analysis
• Figure 2 COVID-19 Impact Analysis on Molecular Modeling Market
• Figure 3 Molecular Modeling Market in Global (2021-2030)
• Figure 4 Molecular Modeling Market in Global by Product Type (2021-2030)
• Figure 5 Molecular Modeling Market in Global by Application (2021-2030)
• Figure 6 Molecular Modeling Market in Global by Distribution Channels (2021-2030)
• Figure 7 Molecular Modeling Market in Global by Geography (2021-2030)
• Figure 8 Molecular Modeling Market in North America (2021-2030)
• Figure 9 Molecular Modeling Market in North America by Country (2021-2030)
• Figure 10 Molecular Modeling Market in the US (2021-2030)
• Figure 11 Molecular Modeling Market in Canada (2021-2030)
• Figure 12 Molecular Modeling Market in Mexico (2021-2030)
• Figure 13 Molecular Modeling Market in Europe (2021-2030)
• Figure 14 Molecular Modeling Market in Europe by Country (2021-2030)
• Figure 15 Molecular Modeling Market in France (2021-2030)
• Figure 16 Molecular Modeling Market in Germany (2021-2030)
• Figure 17 Molecular Modeling Market in the United Kingdom (2021-2030)
• Figure 18 Molecular Modeling Market in Italy (2021-2030)
• Figure 19 Molecular Modeling Market in Spain (2021-2030)
• Figure 20 Molecular Modeling Market in Rest of Europe (2021-2030)
• Figure 21 Molecular Modeling Market in APAC (2021-2030)
• Figure 22 Molecular Modeling Market in APAC by Country (2021-2030)
• Figure 23 Molecular Modeling Market in China (2021-2030)
• Figure 24 Molecular Modeling Market in Japan (2021-2030)
• Figure 25 Molecular Modeling Market in India (2021-2030)
• Figure 26 Molecular Modeling Market in Australia (2021-2030)
• Figure 27 Molecular Modeling Market in South Korea (2021-2030)
• Figure 28 Molecular Modeling Market in Rest of APAC (2021-2030)
• Figure 29 Molecular Modeling Market in Rest of World (2021-2030)
• Figure 30 Molecular Modeling Market in RoW by Region (2021-2030)
• Figure 31 Molecular Modeling Market in Middle East (2021-2030)
• Figure 32 Molecular Modeling Market in Africa (2021-2030)
• Figure 33 Molecular Modeling Market in South America (2021-2030)
• Figure 34 Market Drivers
• Figure 35 Market Barriers
• Figure 36 Marker Opportunities
• Figure 37 PORTER'S Five Force Analysis

MOLECULAR MODELING MARKET BY PRODUCT TYPE (SOFTWARE AND SERVICES), BY END-USER (BIOTECH AND PHARMACEUTICAL INDUSTRIES, RESEARCH ORGANISATIONS, AND OTHERS), BY GEOGRAPHY IS ESTIMATED TO REGISTER GROWTH AT A REMARKABLE CAGR FORECAST DURING 2024-2030 OWING TO INCREASING RESEARCH AND DRUG DEVELOPMENT ACTIVITIES AND RISING PREVALENCE OF MULTIPLE CHRONIC DISEASES.

The global molecular modeling market is estimated to grow at a CAGR of 14.73% during the forecast period from 2024 to 2030. The molecular modeling market is slated to witness prosperity owing to growing prevalence of chronic diseases such as cancer, cardiovascular, lung, and kidney diseases among others. The rise in number of collaborations and mergers between companies for the discovery of novel drugs is another factor for the growth of molecular modeling market. The growing technological advancements w.r.t. molecular modeling, and growing focus on improving the safety, and affordability of drugs and other medications is further expected to result in the appreciable revenue growth in the molecular modeling market during the forecast period (2024-2030).

MOLECULAR MODELING MARKET DYNAMICS:

The noteworthy drivers of the molecular modeling market includes rising prevalence of chronic diseases, increasing industry collaborations and mergers, and increasing research and development activities for the discovery of novel drug therapeutics among others.

Cancer is a deadly disease with no permanent cure till date and therefore rising prevalence of different cancer types such as breast, lung, cervical, oral, and others turns out to be an important driver for the market growth of molecular modeling market which can help in the discovery of novel drug candidates that are effective in cancer treatment. As per the data cited by the World Health Organization 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases colon and rectum, 1.41 million cases of prostate, and 1.09 million cases stomach cancer were reported in 2020.

The increasing prevalence of hard to treat neurological diseases such as Alzheimer's disease (AD), Huntington's disease (HD), Parkinson's disease (PD), and multiple sclerosis (MS) among others will require the discovery of safer and efficient drug molecules for their treatment and management. As per the World Health Organization (WHO) 2022, in present there are around 55 million people suffering from dementia and every year million cases of dementia takes place. The data provided by the WHO 2022, worldwide around 8.5 million people had Parkinson's disease (PD) in 2019 and as per the same source PD lead to 5.8 million disability-adjusted life years.

This indicates the growing need of molecular modeling technologies that assist in the process of drug discovery and development, positively impacting the molecular modeling market.

The increasing number of collaborations and mergers for the discovery and development of novel drug candidates are likely to increase the market growth for molecular marketing. In August 2022, BioDuro-Sundia, leading drug discovery, development and commercial service CRDMO and X-Chem, a DEL technology pioneer in small molecule drug discovery, announced the launch of DNA Encoded Compound Library (DEL) technology services in China to help more innovative pharmaceutical companies quickly discover small molecule drugs.

However, lack of trained and skilled professionals and lack of understanding on disease pathologies may act as a restraint in the market growth for molecular modeling market.

The molecular modeling market reported a short period of restraint in the market growth due to the implementation of lockdown as a necessary step to stop the spread of COVID-19 infection. The various ongoing activities related to drug discovery and development process in different biotech and pharmaceutical industries were hampered for a short period of time during the course of pandemic owing to lockdown impositions and border closures. However, with the resumption of activities across industries, there has been rising demand for molecular modeling owing to risk of emerging and remerging viruses and growing prevalence of other chronic diseases where there is urgent need of novel and effective drug therapeutics. The post COVID scenario is going to be uplifting for the molecular modeling market during the forecast period from 2024-2030.

MOLECULAR MODELING MARKET SEGMENT ANALYSIS:

Molecular Modeling Market by Product Type (Software and Services), Application (Drug Discovery and Drug Development), End-User (Biotech and Pharmaceutical Industries, Research Organizations, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Based on the product type segment of molecular modeling the software category is expected to register a significant growth in coming years owing to their applications in drug discovery and development process.

In field of drug discovery and development molecular modeling software turn out to be a powerful tool for getting information on pharmacokinetics and pharmacodynamics properties of drug molecules.

Molecular modeling provides structure activity relationships between the ligand and target molecules, therefore making the process of drug discovery and development comparatively easier and fast.

Molecular modeling software are inexpensive and help in investigating, identifying, explaining and doing interpretations of molecular characteristics using 3D structures.

For example, Maestro is a molecular modeling software by Schrodinger, Inc. that helps in target validation, hit discovery, lead optimization and allows to read molecules in multiple formats, create and edit structures, and generate design ideas to facilitate molecular exploration.

Therefore, considering the advantages and applications associated with molecular modeling and their growing popularity among end users, this product category is expected to generate considerable revenue thereby pushing the overall growth of the global molecular modeling market during the forecast period.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL MOLECULAR MODELING MARKET:

Among all the regions, North America is expected to lead in revenue generation in the global molecular modeling market. This can be due to the factors including prevalence of chronic diseases, presence of key companies, high-tech facilities, and others.

One of the prominent factors supporting the growth of the North America molecular modeling market is the increasing need of newer drugs owing to the prevalence of cardiovascular diseases. As per the Centers for Disease Control and Prevention (CDC) 2022, around 20.1 million adults suffered from coronary heart disease in the US in 2020.

As per the figures mentioned by the American Cancer Society 2022, it was estimated that 1.9 million new cancer cases have been diagnosed in the United States in the year 2023. Also, according to the data provided by the Centers for Disease Control and Prevention (CDC) 2022, around 1,752,735 new cases of cancer were reported in the US in 2019.

Therefore, along with the presence of large patient pool in the country, the presence of key players including Schrodinger Inc., Simulations Plus, Chemical Computing Group ULC, and others involved in launching new and innovative molecular modeling platforms for the discovery of drug molecules in the region is expected to bolster the growth of the molecular modeling market in the United States during the forecast period.

MOLECULAR MODELING MARKET KEY PLAYERS:

Some of the key market players operating in the molecular modeling market includes Schrodinger, Inc., Cresset, Optibrium, Ltd., BioSolveIT GmbH, Simulations Plus, Chemical Computing Group ULC, Certara, Cadence Molecular Sciences, Wavefunction, Inc., Physiomics Plc, Genedata AG, Rosa & Co. LLC., Acellera, Dassault Systemes, FQS POLAND SP. Z O.O, Molsoft LLC, GTB Pharmaceutical, Intel Corporation, Nanome Inc, Agile Molecule, and others.

RECENT DEVELOPMENTAL ACTIVITIES IN MOLECULAR MODELING MARKET:

In July 2022, OpenEye Scientific Software, Inc., a leading provider of computational molecular modeling and simulation software was acquired by Cadence

In February 2019, RxCelerate, a drug discovery and development company acquires cutting-edge molecular modelling company Prosarix

KEY TAKEAWAYS FROM THE MOLECULAR MODELING MARKET REPORT STUDY

• Market size analysis for current molecular modeling market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the molecular modeling market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened for last 3 years
• Key companies dominating the global molecular modeling market.
• Various opportunities available for the other competitor in the molecular modeling market space.
• What are the top performing segments in 2023? How these segments will perform in 2027.
• Which is the top-performing regions and countries in the current molecular modeling market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for molecular modeling market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS MOLECULAR MODELING MARKET REPORT STUDY

• Molecular modeling market products providers
• Research organizations and consulting companies
• Molecular modeling market-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in walking assist devices
• Various end users who want to know more about the molecular modeling market and latest technological developments in the molecular modeling market.

FREQUENTLY ASKED QUESTIONS FOR MOLECULAR MODELING MARKET:

1. What are the molecular modeling market?

Molecular modeling comprises of the computational techniques and methods designed for the generation, manipulation, and representation of biological molecules and is used as an essential tool in the process of drug discovery and development.

2. What is the market for the global molecular modeling market?

The global molecular modeling market is estimated to grow at a CAGR of 14.73% during the forecast period from 2024 to 2030.

3. What are the drivers for the global molecular modeling market?

The molecular modeling market is slated to witness prosperity owing to factors such as growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and others. The rise in research and development activities for the discovery and development of novel drug therapeutics and the growing focus on developing the safe and affordable drug products are further expected to result in the appreciable revenue growth in the molecular modeling market during the forecast period (2024-2030).

4. Who are the key players operating in the global molecular modeling market?

Some of the key market players operating in the molecular modeling market includes Schrodinger, Inc., Cresset, Optibrium, Ltd., BioSolveIT GmbH, Simulations Plus, Chemical Computing Group ULC, Certara, Cadence Molecular Sciences, Wavefunction, Inc., Physiomics Plc, Genedata AG, Rosa & Co. LLC., Acellera, Dassault Systemes, FQS POLAND SP. Z O.O, Molsoft LLC, GTB Pharmaceutical, Intel Corporation, Nanome Inc, Agile Molecule, and others

5. Which region has the highest share in the molecular modeling market?

North America is expected to dominate the overall molecular modeling market during the forecast period, 2024 to 2030. This can be ascribed to the presence of large patient pool associated with various chronic diseases such as cancer, and others. The rising healthcare expenditure and local presence of key market players are other factors for positive growth of the molecular modeling in the region.

Table of Contents

1. Molecular Modeling Market Report Introduction

2. Molecular Modeling Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory Analysis

• 3.1 The United States
• 3.2 Europe
• 3.3 Japan
• 3.4 China

4. Molecular Modeling Market Key Factors Analysis

• 4.1 Molecular Modeling Market Drivers
  • 4.1.1 Increasing prevalence of chronic diseases
  • 4.1.2 Rising demand for novel drug therapeutics
  • 4.1.3 Increasing number of collaborations w.r.t drug discovery
  • 4.1.4 Increasing risk for emerging and remerging viruses
• 4.2 Molecular Modeling Market Restraints and Challenges
  • 4.2.1 Lack of understanding on disease pathologies
  • 4.2.2 Lack of trained and skilled professionals
• 4.3 Molecular Modeling Market Opportunities
  • 4.3.1 Increasing healthcare expenditure
  • 4.3.2 Technological advancements w.r.t. molecular modeling

5. Molecular Modeling Market Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Molecular Modeling Market

7. Molecular Modeling Market Layout

• 7.1 By Type
  • 7.1.1 Software
  • 7.1.2 Services
• 7.2 By Application
  • 7.2.1 Drug Discovery
  • 7.2.2 Drug Development
• 7.4 By End-users
  • 7.4.1 Biotech and Pharmaceutical Industries
  • 7.4.2 Research Organisations
  • 7.4.3 Others
• 7.4 By Geography
  • 7.4.1 North America
    • 7.4.1.1 United States Molecular Modeling Market in USD million (2021-2030)
    • 7.4.1.2 Canada Molecular Modeling Market in USD million (2021-2030)
    • 7.4.1.3 Mexico Molecular Modeling Market in USD million (2021-2030)
  • 7.4.2 Europe
    • 7.4.2.1 France Molecular Modeling Market in USD million (2021-2030)
    • 7.4.2.2 Germany Molecular Modeling Market in USD million (2021-2030)
    • 7.4.2.3 United Kingdom Molecular Modeling Market in USD million (2021-2030)
    • 7.4.2.4 Italy Molecular Modeling Market in USD million (2021-2030)
    • 7.4.2.5 Spain Molecular Modeling Market in USD million (2021-2030)
    • 7.4.2.6 Rest of Europe Molecular Modeling Market in USD million (2021-2030)
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 China Molecular Modeling Market in USD million (2021-2030)
    • 7.4.3.2 Japan Molecular Modeling Market in USD million (2021-2030)
    • 7.4.3.3 India Molecular Modeling Market in USD million (2021-2030)
    • 7.4.3.4 Australia Molecular Modeling Market in USD million (2021-2030)
    • 7.4.3.5 South Korea Molecular Modeling Market in USD million (2021-2030)
    • 7.4.3.6 Rest of Asia Pacific Molecular Modeling Market in USD million (2021-2030)
  • 7.4.4 Rest of the World (RoW)
    • 7.4.4.1. Middle East Molecular Modeling Market in USD million (2021-2030)
    • 7.4.4.2 Africa Molecular Modeling Market in USD million (2021-2030)
    • 7.4.4.3 South America Molecular Modeling Market in USD million (2021-2030)

8. Molecular Modeling Market Global Company Share Analysis - Key 3-5 Companies

9. Molecular Modeling Market Company and Product Profiles

• 9.1 Cresset
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2 Schrodinger, Inc.
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3 Optibrium, Ltd.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4 BioSolveIT GmbH
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5 Simulations Plus
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6 Chemical Computing Group ULC
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7 Certara
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.5. Product Listing
  • 9.7.5. Entropy
• 9.8 Cadence Molecular Sciences
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9 Wavefunction, Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10 Physiomics Plc
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11 Genedata AG
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12 Rosa & Co. LLC.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13 Acellera
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14 Dassault Systemes
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15 FQS POLAND SP. Z O.O
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16 Molsoft LLC
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17 GTB Pharmaceutical
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.5. Product Listing
  • 9.17.5. Entropy
• 9.18 Intel Corporation
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy
• 9.19 Nanome Inc
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4. Product Listing
  • 9.19.5. Entropy
• 9.20 Agile Molecule
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4. Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us